<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36653804</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1750-1326</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>18</Day></PubDate></JournalIssue><Title>Molecular neurodegeneration</Title><ISOAbbreviation>Mol Neurodegener</ISOAbbreviation></Journal><ArticleTitle>FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanisms.</ArticleTitle><Pagination><StartPage>5</StartPage><MedlinePgn>5</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13024-022-00591-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Astrocytes play a crucial, yet not fully elucidated role in the selective motor neuron pathology in amyotrophic lateral sclerosis (ALS). Among other responsibilities, astrocytes provide important neuronal homeostatic support, however this function is highly compromised in ALS. The establishment of fully human coculture systems can be used to further study the underlying mechanisms of the dysfunctional intercellular interplay, and has the potential to provide a platform for revealing novel therapeutic entry points.</AbstractText><AbstractText Label="METHODS">In this study, we characterised human induced pluripotent stem cell (hiPSC)-derived astrocytes from FUS-ALS patients, and incorporated these cells into a human motor unit microfluidics model to investigate the astrocytic effect on hiPSC-derived motor neuron network and functional neuromuscular junctions (NMJs) using immunocytochemistry and live-cell recordings. FUS-ALS cocultures were systematically compared to their CRISPR-Cas9 gene-edited isogenic control systems.</AbstractText><AbstractText Label="RESULTS">We observed a dysregulation of astrocyte homeostasis, which resulted in a FUS-ALS-mediated increase in reactivity and secretion of inflammatory cytokines. Upon coculture with motor neurons and myotubes, we detected a cytotoxic effect on motor neuron-neurite outgrowth, NMJ formation and functionality, which was improved or fully rescued by isogenic control astrocytes. We demonstrate that ALS astrocytes have both a gain-of-toxicity and loss-of-support function involving the WNT/&#x3b2;-catenin pathway, ultimately contributing to the disruption of motor neuron homeostasis, intercellular networks and NMJs.</AbstractText><AbstractText Label="CONCLUSIONS">Our findings shine light on a complex, yet highly important role of astrocytes in ALS, and provides further insight in to their pathological mechanisms.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stoklund Dittlau</LastName><ForeName>Katarina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2776-2892</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology and Leuven Brain Institute, KU Leuven - University of Leuven, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Laboratory of Neurobiology, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terrie</LastName><ForeName>Lisanne</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-6274-0624</Identifier><AffiliationInfo><Affiliation>Department of Development and Regeneration, KU Leuven - University of Leuven, Campus Kulak, 8500, Kortrijk, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baatsen</LastName><ForeName>Pieter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-4500-581X</Identifier><AffiliationInfo><Affiliation>KU Leuven - University of Leuven, EM-Platform of the VIB Bio Imaging Core and VIB Center for Brain and Disease Research, Research Group Molecular Neurobiology, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerstens</LastName><ForeName>Axelle</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>KU Leuven - University of Leuven, VIB Bio Imaging Core; VIB Center for Brain &amp; Disease Research, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Swert</LastName><ForeName>Lim</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>VIB Nucleomics Core, VIB, Herestraat 49, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janky</LastName><ForeName>Rekin's</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5135-2469</Identifier><AffiliationInfo><Affiliation>VIB Nucleomics Core, VIB, Herestraat 49, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corthout</LastName><ForeName>Nikky</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-1176-7277</Identifier><AffiliationInfo><Affiliation>KU Leuven - University of Leuven, VIB Bio Imaging Core; VIB Center for Brain &amp; Disease Research, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masrori</LastName><ForeName>Pegah</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-8247-1866</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology and Leuven Brain Institute, KU Leuven - University of Leuven, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Laboratory of Neurobiology, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Damme</LastName><ForeName>Philip</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4010-2357</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology and Leuven Brain Institute, KU Leuven - University of Leuven, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Laboratory of Neurobiology, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyttel</LastName><ForeName>Poul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, 1870, Frederiksberg C, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Morten</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9571-1336</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Odense University Hospital, 5000, Odense, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, 5000, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thorrez</LastName><ForeName>Lieven</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-5896-6823</Identifier><AffiliationInfo><Affiliation>Department of Development and Regeneration, KU Leuven - University of Leuven, Campus Kulak, 8500, Kortrijk, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freude</LastName><ForeName>Kristine</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9480-2386</Identifier><AffiliationInfo><Affiliation>Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, 1870, Frederiksberg C, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Den Bosch</LastName><ForeName>Ludo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology and Leuven Brain Institute, KU Leuven - University of Leuven, 3000, Leuven, Belgium. ludo.vandenbosch@kuleuven.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Laboratory of Neurobiology, 3000, Leuven, Belgium. ludo.vandenbosch@kuleuven.be.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Neurodegener</MedlineTA><NlmUniqueID>101266600</NlmUniqueID><ISSNLinking>1750-1326</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Astrocyte</Keyword><Keyword MajorTopicYN="N">Cytokines</Keyword><Keyword MajorTopicYN="N">Microfluidic</Keyword><Keyword MajorTopicYN="N">Motor unit</Keyword><Keyword MajorTopicYN="N">Neuromuscular junction</Keyword><Keyword MajorTopicYN="N">Reactivity</Keyword><Keyword MajorTopicYN="N">WNT/&#x3b2;-catenin pathway</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>18</Day><Hour>23</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36653804</ArticleId><ArticleId IdType="pmc">PMC9847053</ArticleId><ArticleId IdType="doi">10.1186/s13024-022-00591-3</ArticleId><ArticleId IdType="pii">10.1186/s13024-022-00591-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27(10):1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Shatunov A, Al-Chalabi A. The genetic architecture of ALS. Neurobiol Dis. 2021;147:105156. doi: 10.1016/j.nbd.2020.105156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105156</ArticleId><ArticleId IdType="pubmed">33130222</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP. Genetic epidemiology of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88(7):540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Picher-Martel V, Brunet F, Dupr&#xe9; N, Chrestian N. The Occurrence of FUS Mutations in Pediatric Amyotrophic Lateral Sclerosis: A Case Report and Review of the Literature. J Child Neurol. 2020;35(8):556&#x2013;562. doi: 10.1177/0883073820915099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0883073820915099</ArticleId><ArticleId IdType="pubmed">32281455</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack GE, Luisier R, Taha DM, Neeves J, Modic M, Mitchell JS, et al. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis. Brain. 2019;142(9):2572&#x2013;2580. doi: 10.1093/brain/awz217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz217</ArticleId><ArticleId IdType="pmc">PMC6735815</ArticleId><ArticleId IdType="pubmed">31368485</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan M, Talbot K, Ansorge O. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models. Acta Neuropathol Commun. 2016;4(1):99. doi: 10.1186/s40478-016-0358-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0358-8</ArticleId><ArticleId IdType="pmc">PMC5011941</ArticleId><ArticleId IdType="pubmed">27600654</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol. 2011;29(9):824&#x2013;828. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci. 2008;11(3):251&#x2013;253. doi: 10.1038/nn2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio FP, Boulting GL, Bobrowicz S, Eggan KC. Human Embryonic Stem Cell-Derived Motor Neurons Are Sensitive to the Toxic Effect of Glial Cells Carrying an ALS-Causing Mutation. Cell Stem Cell. 2008;3(6):637&#x2013;648. doi: 10.1016/j.stem.2008.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2008.09.017</ArticleId><ArticleId IdType="pubmed">19041780</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajmone-Cat MA, Onori A, Toselli C, Stronati E, Morlando M, Bozzoni I, et al. Increased FUS levels in astrocytes leads to astrocyte and microglia activation and neuronal death. Sci Rep. 2019;9(1):4572. doi: 10.1038/s41598-019-41040-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-41040-4</ArticleId><ArticleId IdType="pmc">PMC6418113</ArticleId><ArticleId IdType="pubmed">30872738</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian K, Huang H, Peterson A, Hu B, Maragakis NJ, Ming G li, et al. Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo. Stem Cell Reports. 2017;8(4):843&#x2013;55. doi: 10.1016/j.stemcr.2017.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.03.003</ArticleId><ArticleId IdType="pmc">PMC5390239</ArticleId><ArticleId IdType="pubmed">28366455</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan KA, Weigel MK, Adler DI, Couthouis J, Liddelow SA, Gitler AD, et al. Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model. Nat Commun. 2020;11(1):3753. doi: 10.1038/s41467-020-17514-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17514-9</ArticleId><ArticleId IdType="pmc">PMC7385161</ArticleId><ArticleId IdType="pubmed">32719333</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall ED, Oostveen JA, Gurney ME. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia. 1998;23(3):249&#x2013;256. doi: 10.1002/(SICI)1098-1136(199807)23:3&lt;249::AID-GLIA7&gt;3.0.CO;2-#.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-1136(199807)23:3&lt;249::AID-GLIA7&gt;3.0.CO;2-#</ArticleId><ArticleId IdType="pubmed">9633809</ArticleId></ArticleIdList></Reference><Reference><Citation>Haim LB, Rowitch DH. Functional diversity of astrocytes in neural circuit regulation. Nat Rev Neurosci. 2017;18(1):31&#x2013;41. doi: 10.1038/nrn.2016.159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2016.159</ArticleId><ArticleId IdType="pubmed">27904142</ArticleId></ArticleIdList></Reference><Reference><Citation>Staats KA, Van Den Bosch L. Astrocytes in amyotrophic lateral sclerosis: Direct effects on motor neuron survival. J Biol Phys. 2009;35(4):337&#x2013;346. doi: 10.1007/s10867-009-9141-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10867-009-9141-4</ArticleId><ArticleId IdType="pmc">PMC2750739</ArticleId><ArticleId IdType="pubmed">19669429</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerisis. Ann Neurol. 1995;38(1):73&#x2013;84. doi: 10.1002/ana.410380114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410380114</ArticleId><ArticleId IdType="pubmed">7611729</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron. 1996;16(3):675&#x2013;686. doi: 10.1016/S0896-6273(00)80086-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80086-0</ArticleId><ArticleId IdType="pubmed">8785064</ArticleId></ArticleIdList></Reference><Reference><Citation>Madji Hounoum B, Mavel S, Coque E, Patin F, Vourc&#x2019;h P, Marouillat S, et al. Wildtype motoneurons, ALS-Linked SOD1 mutation and glutamate profoundly modify astrocyte metabolism and lactate shuttling. Glia. 2017;65(4):592&#x2013;605. doi: 10.1002/glia.23114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23114</ArticleId><ArticleId IdType="pubmed">28139855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Higginbottom A, Heath PR, Barber S, Greenald D, Kirby J, et al. Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain. 2011;134(9):2627&#x2013;2641. doi: 10.1093/brain/awr193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr193</ArticleId><ArticleId IdType="pmc">PMC3170534</ArticleId><ArticleId IdType="pubmed">21908873</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpern M, Brennand KJ, Gregory J. Examining the relationship between astrocyte dysfunction and neurodegeneration in ALS using hiPSCs. Neurobiol Dis. 2019;132:104562. doi: 10.1016/j.nbd.2019.104562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104562</ArticleId><ArticleId IdType="pmc">PMC6834907</ArticleId><ArticleId IdType="pubmed">31381978</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci. 2007;10(5):615&#x2013;622. doi: 10.1038/nn1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi P, Rodriguez-Muela N, Klim JR, de Boer AS, Agrawal S, Sandoe J, et al. Reactive Astrocytes Promote ALS-like Degeneration and Intracellular Protein Aggregation in Human Motor Neurons by Disrupting Autophagy through TGF-&#x3b2;1. Stem Cell Reports. 2017;9(2):667&#x2013;680. doi: 10.1016/j.stemcr.2017.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.06.008</ArticleId><ArticleId IdType="pmc">PMC5549875</ArticleId><ArticleId IdType="pubmed">28712846</ArticleId></ArticleIdList></Reference><Reference><Citation>Kia A, McAvoy K, Krishnamurthy K, Trotti D, Pasinelli P. Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha. Glia. 2018;66(5):1016&#x2013;1033. doi: 10.1002/glia.23298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23298</ArticleId><ArticleId IdType="pmc">PMC5873384</ArticleId><ArticleId IdType="pubmed">29380416</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetto MCN, Muotri AR, Mu Y, Smith AM, Cezar GG, Gage FH. Non-Cell-Autonomous Effect of Human SOD1G37R Astrocytes on Motor Neurons Derived from Human Embryonic Stem Cells. Cell Stem Cell. 2008;3(6):649&#x2013;657. doi: 10.1016/j.stem.2008.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2008.10.001</ArticleId><ArticleId IdType="pubmed">19041781</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoklund Dittlau K, Krasnow EN, Fumagalli L, Vandoorne T, Baatsen P, Kerstens A, et al. Human motor units in microfluidic devices are impaired by FUS mutations and improved by HDAC6 inhibition. Stem Cell Reports. 2021;16(9):2213&#x2013;2227. doi: 10.1016/j.stemcr.2021.03.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.03.029</ArticleId><ArticleId IdType="pmc">PMC8452598</ArticleId><ArticleId IdType="pubmed">33891869</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoklund Dittlau K, Krasnow EN, Fumagalli L, Vandoorne T, Baatsen P, Kerstens A, et al. Generation of Human Motor Units with Functional Neuromuscular Junctions in Microfluidic Devices. J Vis Exp. 2021;175:e62959.</Citation><ArticleIdList><ArticleId IdType="pubmed">34570099</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Naujock M, Fumagalli L, Vandoorne T, Baatsen P, Boon R, et al. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat Commun. 2017;8(1):861. doi: 10.1038/s41467-017-00911-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00911-y</ArticleId><ArticleId IdType="pmc">PMC5636840</ArticleId><ArticleId IdType="pubmed">29021520</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Guo W, Mitra J, Hegde PM, Vandoorne T, Eckelmann BJ, et al. Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis. Nat Commun. 2018;9:3683. doi: 10.1038/s41467-018-06111-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06111-6</ArticleId><ArticleId IdType="pmc">PMC6134028</ArticleId><ArticleId IdType="pubmed">30206235</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrasekaran A, Stoklund Dittlau K, Corsi GI, Haukedal H, Doncheva NT, Ramakrishna S, et al. Astrocytic reactivity triggered by defective autophagy and metabolic failure causes neurotoxicity in frontotemporal dementia type 3. Stem Cell Reports. 2021;16(11):2736&#x2013;2751. doi: 10.1016/j.stemcr.2021.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.09.013</ArticleId><ArticleId IdType="pmc">PMC8581052</ArticleId><ArticleId IdType="pubmed">34678206</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury Y, C&#xf4;me J, Piskorowski RA, Salah-Mohellibi N, Chevaleyre V, Peschanski M, et al. Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. Nat Biotechnol. 2015;33(1):89&#x2013;96. doi: 10.1038/nbt.3049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3049</ArticleId><ArticleId IdType="pubmed">25383599</ArticleId></ArticleIdList></Reference><Reference><Citation>Gholobova D, Gerard M, Terrie L, Desender L, Shansky J, Vandenburgh H, et al. Co-culture method to obtain endothelial networks within human tissue-engineered skeletal muscle. In: R&#xf8;nning S, et al., editors. Myogenesis Methods in Molecular Biology, vol 1889 Humana Press. New York: NY; 2019. pp. 169&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">30367414</ArticleId></ArticleIdList></Reference><Reference><Citation>HannonLab . Fastx-toolkit. 2010.</Citation></Reference><Reference><Citation>Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17(1):10&#x2013;12.</Citation></Reference><Reference><Citation>Morgan M, Anders S, Lawrence M, Aboyoun P, Pages H, Gentleman R. ShortRead: a bioconductor package for input, quality assessment and exploration of high-throughput sequence data. Bioinformatics. 2009;25(19):2607&#x2013;2608. doi: 10.1093/bioinformatics/btp450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp450</ArticleId><ArticleId IdType="pmc">PMC2752612</ArticleId><ArticleId IdType="pubmed">19654119</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmead B, Salzberg S. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357&#x2013;359. doi: 10.1038/nmeth.1923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1923</ArticleId><ArticleId IdType="pmc">PMC3322381</ArticleId><ArticleId IdType="pubmed">22388286</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25(16):2078&#x2013;2079. doi: 10.1093/bioinformatics/btp352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp352</ArticleId><ArticleId IdType="pmc">PMC2723002</ArticleId><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Smyth GK, Shi W. FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923&#x2013;930. doi: 10.1093/bioinformatics/btt656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt656</ArticleId><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Risso D, Schwartz K, Sherlock G, Dudoit S. GC-Content Normalization for RNA-Seq Data. BMC Bioinformatics. 2011;12:480. doi: 10.1186/1471-2105-12-480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-12-480</ArticleId><ArticleId IdType="pmc">PMC3315510</ArticleId><ArticleId IdType="pubmed">22177264</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, Smyth GK. Moderated statistical tests for assessing differences in tag abundance. Bioinformatics. 2007;23(21):2881&#x2013;2887. doi: 10.1093/bioinformatics/btm453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btm453</ArticleId><ArticleId IdType="pubmed">17881408</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Hochberg Y. Controlling the False Discovery Rate : A Practical and Powerful Approach to Multiple Testing. J R Stat Soc. 1995;57(1):289&#x2013;300.</Citation></Reference><Reference><Citation>Birger A, Ben-Dor I, Ottolenghi M, Turetsky T, Gil Y, Sweetat S, et al. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine. 2019;50:274&#x2013;289. doi: 10.1016/j.ebiom.2019.11.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.11.026</ArticleId><ArticleId IdType="pmc">PMC6921360</ArticleId><ArticleId IdType="pubmed">31787569</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32(18):2847&#x2013;2849. doi: 10.1093/bioinformatics/btw313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw313</ArticleId><ArticleId IdType="pubmed">27207943</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xe4;mer A, Green J, Pollard J, Tugendreich S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 2014;30(4):523&#x2013;530. doi: 10.1093/bioinformatics/btt703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt703</ArticleId><ArticleId IdType="pmc">PMC3928520</ArticleId><ArticleId IdType="pubmed">24336805</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi H, Muruganujan A, Thomas PD. PANTHER in 2013: Modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res. 2013;41(D1):D377&#x2013;D386. doi: 10.1093/nar/gks1118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks1118</ArticleId><ArticleId IdType="pmc">PMC3531194</ArticleId><ArticleId IdType="pubmed">23193289</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, Daverman R, et al. PANTHER: A library of protein families and subfamilies indexed by function. Genome Res. 2003;13(9):2129&#x2013;2141. doi: 10.1101/gr.772403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.772403</ArticleId><ArticleId IdType="pmc">PMC403709</ArticleId><ArticleId IdType="pubmed">12952881</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-&#x394;&#x394;CT method. Methods. 2001;25(4):402&#x2013;408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg S, Kutra D, Kroeger T, Straehle CN, Kausler BX, Haubold C, et al. Ilastik: Interactive Machine Learning for (Bio)Image Analysis. Nat Methods. 2019;16(12):1226&#x2013;1232. doi: 10.1038/s41592-019-0582-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0582-9</ArticleId><ArticleId IdType="pubmed">31570887</ArticleId></ArticleIdList></Reference><Reference><Citation>Taha DM, Clarke BE, Hall CE, Tyzack GE, Ziff OJ, Greensmith L, et al. Astrocytes display cell autonomous and diverse early reactive states in familial amyotrophic lateral sclerosis. Brain. 2022;145(2):481&#x2013;489. doi: 10.1093/brain/awab328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab328</ArticleId><ArticleId IdType="pmc">PMC9014746</ArticleId><ArticleId IdType="pubmed">35042241</ArticleId></ArticleIdList></Reference><Reference><Citation>Escartin C, Galea E, Lakatos A, O&#x2019;Callaghan JP, Petzold GC, Serrano-Pozo A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24(3):312&#x2013;325. doi: 10.1038/s41593-020-00783-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00783-4</ArticleId><ArticleId IdType="pmc">PMC8007081</ArticleId><ArticleId IdType="pubmed">33589835</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J-M, An J. Cytokines. Inflammation and Pain Int Anesth Clin. 2007;45(2):27&#x2013;37. doi: 10.1097/AIA.0b013e318034194e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AIA.0b013e318034194e</ArticleId><ArticleId IdType="pmc">PMC2785020</ArticleId><ArticleId IdType="pubmed">17426506</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481&#x2013;487. doi: 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Fern&#xe1;ndez C, Gonzalez P, Andres-Benito P, Ferrer I, Rodr&#xed;guez FJ. Wnt Signaling Alterations in the Human Spinal Cord of Amyotrophic Lateral Sclerosis Cases: Spotlight on Fz2 and Wnt5a. Mol Neurobiol. 2019;56(10):6777&#x2013;6791. doi: 10.1007/s12035-019-1547-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1547-9</ArticleId><ArticleId IdType="pubmed">30924074</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang X, Guan Y, Zhao Z, Meng F, Wang X, Gao X, et al. Potential roles of the WNT signaling pathway in amyotrophic lateral sclerosis. Cells. 2021;10(4):839. doi: 10.3390/cells10040839.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10040839</ArticleId><ArticleId IdType="pmc">PMC8068170</ArticleId><ArticleId IdType="pubmed">33917816</ArticleId></ArticleIdList></Reference><Reference><Citation>Jridi I, Cant&#xe9;-Barrett K, Pike-Overzet K, Staal FJT. Inflammation and Wnt Signaling: Target for Immunomodulatory Therapy? Front Cell Dev Biol. 2021;8:615131. doi: 10.3389/fcell.2020.615131.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.615131</ArticleId><ArticleId IdType="pmc">PMC7890028</ArticleId><ArticleId IdType="pubmed">33614624</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L, Guan Y, Wu X, Chen Y, Liu Z, Du H, et al. Wnt signaling is altered by spinal cord neuronal dysfunction in amyotrophic lateral sclerosis transgenic mice. Neurochem Res. 2013;38(9):1904&#x2013;1913. doi: 10.1007/s11064-013-1096-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-013-1096-y</ArticleId><ArticleId IdType="pmc">PMC4170800</ArticleId><ArticleId IdType="pubmed">23784673</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Fernandez C, Gonz&#xe1;lez P, Rodr&#xed;guez F. New insights into Wnt signaling alterations in amyotrophic lateral sclerosis: A potential therapeutic target? Neural Regen Res. 2020;15(9):1580&#x2013;1589. doi: 10.4103/1673-5374.276320.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.276320</ArticleId><ArticleId IdType="pmc">PMC7437582</ArticleId><ArticleId IdType="pubmed">32209757</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley ME, Baloh RH. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. 2019;137(5):715&#x2013;730. doi: 10.1007/s00401-018-1933-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1933-9</ArticleId><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Martinez L, Calvo AC, Mu&#xf1;oz MJ, Osta R. Are circulating cytokines reliable biomarkers for amyotrophic lateral sclerosis? Int J Mol Sci. 2019;20(11):2759. doi: 10.3390/ijms20112759.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20112759</ArticleId><ArticleId IdType="pmc">PMC6600567</ArticleId><ArticleId IdType="pubmed">31195629</ArticleId></ArticleIdList></Reference><Reference><Citation>Mennini T, Giordano L, Mengozzi M, Ghezzi P, Tonelli R, Mantegazza R, et al. Increased IL-8 levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur J Inflamm. 2009;7(1):39&#x2013;44. doi: 10.1177/1721727X0900700105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1721727X0900700105</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhle J, Lindberg RLP, Regeniter A, Mehling M, Steck AJ, Kappos L, et al. Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. Eur J Neurol. 2009;16(6):771&#x2013;774. doi: 10.1111/j.1468-1331.2009.02560.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02560.x</ArticleId><ArticleId IdType="pubmed">19236470</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas F, Cortes N, Abarzua S, Dyrda A, van Zundert B. Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress. Front Cell Neurosci. 2014;8:24. doi: 10.3389/fncel.2014.00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00024</ArticleId><ArticleId IdType="pmc">PMC3916762</ArticleId><ArticleId IdType="pubmed">24570655</ArticleId></ArticleIdList></Reference><Reference><Citation>Arredondo C, Cefaliello C, Dyrda A, Jury N, Martinez P, D&#xed;az I, et al. Excessive release of inorganic polyphosphate by ALS/FTD astrocytes causes non-cell-autonomous toxicity to motoneurons. Neuron. 2022;110(10):1656&#x2013;1670.e12. doi: 10.1016/j.neuron.2022.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.02.010</ArticleId><ArticleId IdType="pmc">PMC9119918</ArticleId><ArticleId IdType="pubmed">35276083</ArticleId></ArticleIdList></Reference><Reference><Citation>Madill M, McDonagh K, Ma J, Vajda A, McLoughlin P, O&#x2019;Brien T, et al. Amyotrophic lateral sclerosis patient iPSC-derived astrocytes impair autophagy via non-cell autonomous mechanisms. Mol Brain. 2017;10(1):22. doi: 10.1186/s13041-017-0300-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0300-4</ArticleId><ArticleId IdType="pmc">PMC5470320</ArticleId><ArticleId IdType="pubmed">28610619</ArticleId></ArticleIdList></Reference><Reference><Citation>Almad AA, Doreswamy A, Gross SK, Richard JP, Huo Y, Haughey N, et al. Connexin 43 in astrocytes contgributes to motor neuron toxicity in amyotrophic lateral scleoris. Glia. 2016;64(7):1154&#x2013;1169. doi: 10.1002/glia.22989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22989</ArticleId><ArticleId IdType="pmc">PMC5635605</ArticleId><ArticleId IdType="pubmed">27083773</ArticleId></ArticleIdList></Reference><Reference><Citation>Almad AA, Taga A, Joseph J, Gross SK, Welsh C, Patankar A, et al. Cx43 hemichannels contribute to astrocyte-mediated toxicity in sporadic and familial ALS. PNAS. 2022;119(13):e2107391119. doi: 10.1073/pnas.2107391119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2107391119</ArticleId><ArticleId IdType="pmc">PMC9060483</ArticleId><ArticleId IdType="pubmed">35312356</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C, Devlin AC, Chouhan AK, Selvaraj BT, Stavrou M, Burr K, et al. Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology. Glia. 2019;68(5):1046&#x2013;1064. doi: 10.1002/glia.23761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23761</ArticleId><ArticleId IdType="pmc">PMC7078830</ArticleId><ArticleId IdType="pubmed">31841614</ArticleId></ArticleIdList></Reference><Reference><Citation>Obaid M, Udden SMN, Deb P, Shihabeddin N, Zaki MH, Mandal SS. LncRNA HOTAIR regulates lipopolysaccharide-induced cytokine expression and inflammatory response in macrophages. Sci Rep. 2018;8:15670. doi: 10.1038/s41598-018-33722-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-33722-2</ArticleId><ArticleId IdType="pmc">PMC6199307</ArticleId><ArticleId IdType="pubmed">30353135</ArticleId></ArticleIdList></Reference><Reference><Citation>Dresselhaus EC, Meffert MK. Cellular specificity of NF-&#x3ba;B function in the nervous system. Front Immunol. 2019;10:1043. doi: 10.3389/fimmu.2019.01043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01043</ArticleId><ArticleId IdType="pmc">PMC6520659</ArticleId><ArticleId IdType="pubmed">31143184</ArticleId></ArticleIdList></Reference><Reference><Citation>Snow WM, Albensi BC. Neuronal gene targets of NF-&#x3ba;B and their dysregulation in alzheimer&#x2019;s disease. Front Mol Neurosci. 2016;9:118. doi: 10.3389/fnmol.2016.00118.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00118</ArticleId><ArticleId IdType="pmc">PMC5101203</ArticleId><ArticleId IdType="pubmed">27881951</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, Phaneuf D, Dupr&#xe9; N, Petri S, Strong M, Kriz J, et al. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor &#x3ba;B-mediated pathogenic pathways. J Exp Med. 2011;208(12):2429&#x2013;2447. doi: 10.1084/jem.20111313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111313</ArticleId><ArticleId IdType="pmc">PMC3256969</ArticleId><ArticleId IdType="pubmed">22084410</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes AE, Ferraiuolo L, Haidet-Phillips AM, Schmelzer L, Braun L, Miranda CJ, et al. Microglia induce motor neuron death via the classical NF-&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron. 2014;81(5):1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Naderi A. Molecular functions of brain expressed X-linked 2 (BEX2) in malignancies. Exp Cell Res. 2019;376(2):221&#x2013;226. doi: 10.1016/j.yexcr.2019.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2019.02.014</ArticleId><ArticleId IdType="pubmed">30779920</ArticleId></ArticleIdList></Reference><Reference><Citation>Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol. 1998;10(2):262&#x2013;267. doi: 10.1016/S0955-0674(98)80149-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0955-0674(98)80149-X</ArticleId><ArticleId IdType="pubmed">9561851</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai D, Ueno L, Vogt P. Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt. Int J Cancer. 2009;125(12):2863&#x2013;2870. doi: 10.1002/ijc.24748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.24748</ArticleId><ArticleId IdType="pmc">PMC2767458</ArticleId><ArticleId IdType="pubmed">19609947</ArticleId></ArticleIdList></Reference><Reference><Citation>Naderi A, Liu J, Hughes-Davies L. BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer. Mol Cancer. 2010;9:111. doi: 10.1186/1476-4598-9-111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-4598-9-111</ArticleId><ArticleId IdType="pmc">PMC2881879</ArticleId><ArticleId IdType="pubmed">20482821</ArticleId></ArticleIdList></Reference><Reference><Citation>Naderi A, Teschendorff AE, Beigel J, Cariati M, Ellis IO, Brenton JD, et al. BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-&#x3ba;B inhibition of apoptosis in breast cancer cell lines. Cancer Res. 2007;67(14):6725&#x2013;6736. doi: 10.1158/0008-5472.CAN-06-4394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-06-4394</ArticleId><ArticleId IdType="pubmed">17638883</ArticleId></ArticleIdList></Reference><Reference><Citation>Crosio C, Valle C, Casciati A, Iaccarino C, Carr&#xec; MT. Astroglial inhibition of NF-&#x3ba;b does not ameliorate disease onset and progression in a mouse model for amyotrophic lateral sclerosis (ALS) PLoS ONE. 2011;6(3):e17187. doi: 10.1371/journal.pone.0017187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017187</ArticleId><ArticleId IdType="pmc">PMC3060799</ArticleId><ArticleId IdType="pubmed">21445241</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J-Y, Chen C. Endocannabinoids in synaptic plasticity and neuroprotection. Neuroscientist. 2015;21(2):152&#x2013;168. doi: 10.1177/1073858414524632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858414524632</ArticleId><ArticleId IdType="pmc">PMC4143501</ArticleId><ArticleId IdType="pubmed">24571856</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamoto K, Karelina K, Obrietan K. CREB: A multifaceted regulator of neuronal plasticity and protection. J Neurochem. 2010;116(1):1&#x2013;9. doi: 10.1111/j.1471-4159.2010.07080.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.07080.x</ArticleId><ArticleId IdType="pmc">PMC3575743</ArticleId><ArticleId IdType="pubmed">21044077</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Ryan TA. CDK5 Serves as a Major Control Point in Neurotransmitter Release. Neuron. 2010;67(5):797&#x2013;809. doi: 10.1016/j.neuron.2010.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.08.003</ArticleId><ArticleId IdType="pmc">PMC2939042</ArticleId><ArticleId IdType="pubmed">20826311</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziff OJ, Clarke BE, Taha DM, Crerar H, Luscombe NM, Patani R. Meta-analysis of human and mouse ALS astrocytes reveals multi-omic signatures of inflammatory reactive states. Genome Res. 2022;32(1):71&#x2013;84. doi: 10.1101/gr.275939.121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.275939.121</ArticleId><ArticleId IdType="pmc">PMC8744676</ArticleId><ArticleId IdType="pubmed">34963663</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriquez JP, Webb A, Bence M, Bildsoe H, Sahores M, Hughes SM, et al. Wnt signaling promotes AChR aggregation at the neuromuscular synapse in collaboration with agrin. PNAS. 2008;105(48):18812&#x2013;18817. doi: 10.1073/pnas.0806300105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0806300105</ArticleId><ArticleId IdType="pmc">PMC2585041</ArticleId><ArticleId IdType="pubmed">19020093</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon LR, Gribble KD, Syrett CM, Granato M. Initiation of synapse formation by Wnt-induced MuSK endocytosis. Development. 2012;139(5):1023&#x2013;1033. doi: 10.1242/dev.071555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.071555</ArticleId><ArticleId IdType="pmc">PMC3274363</ArticleId><ArticleId IdType="pubmed">22318632</ArticleId></ArticleIdList></Reference><Reference><Citation>Mess&#xe9;ant J, Ezan J, Delers P, Glebov K, Marchiol C, Lager F, et al. Wnt proteins contribute to neuromuscular junction formation through distinct signaling pathways. Development. 2017;144(9):1712&#x2013;1724.</Citation><ArticleIdList><ArticleId IdType="pubmed">28348167</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Luo Z-G. The role of Wnt/&#x3b2;-catenin signaling in postsynaptic differentiation. Commun Integr Biol. 2008;1(2):158&#x2013;160. doi: 10.4161/cib.1.2.7099.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cib.1.2.7099</ArticleId><ArticleId IdType="pmc">PMC2686008</ArticleId><ArticleId IdType="pubmed">19704879</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Ruan NJ, Qian L, Lei WL, Chen F, Luo ZG. Wnt/&#x3b2;-catenin signaling suppresses Rapsyn expression and inhibits acetylcholine receptor clustering at the neuromuscular junction. J Biol Chem. 2008;283(31):21668&#x2013;21675. doi: 10.1074/jbc.M709939200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M709939200</ArticleId><ArticleId IdType="pubmed">18541538</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen C, Li L, Zhao K, Bai L, Wang A, Shu X, et al. Motoneuron Wnts regulate neuromuscular junction development. Elife. 2018;7:e34625. doi: 10.7554/eLife.34625.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.34625</ArticleId><ArticleId IdType="pmc">PMC6128691</ArticleId><ArticleId IdType="pubmed">30113308</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez P, Rodr&#xed;guez FJ. Analysis of the expression of the Wnt family of proteins and its modulatory role on cytokine expression in non activated and activated astroglial cells. Neurosci Res. 2017;114:16&#x2013;29. doi: 10.1016/j.neures.2016.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2016.08.003</ArticleId><ArticleId IdType="pubmed">27562517</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto C, Medinas DB, Fuentes-Villalobos F, Maripill&#xe1;n J, Castro AF, Mart&#xed;nez AD, et al. &#x3b2;-catenin aggregation in models of ALS motor neurons: GSK3&#x3b2; inhibition effect and neuronal differentiation. Neurobiol Dis. 2019;130:104497. doi: 10.1016/j.nbd.2019.104497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104497</ArticleId><ArticleId IdType="pubmed">31176720</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins S, Namboori SC, Tariq A, Blaker C, Flaxman C, Dey NS, et al. Upregulation of &#x3b2;-catenin due to loss of miR-139 contributes to motor neuron death in amyotrophic lateral sclerosis. Stem Cell Reports. 2022;17:1650&#x2013;1665. doi: 10.1016/j.stemcr.2022.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2022.05.019</ArticleId><ArticleId IdType="pmc">PMC9287677</ArticleId><ArticleId IdType="pubmed">35750046</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhinge A, Namboori SC, Zhang X, VanDongen AMJ, Stanton LW. Genetic Correction of SOD1 Mutant iPSCs Reveals ERK and JNK Activated AP1 as a Driver of Neurodegeneration in Amyotrophic Lateral Sclerosis. Stem Cell Reports. 2017;8(4):856&#x2013;869. doi: 10.1016/j.stemcr.2017.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.02.019</ArticleId><ArticleId IdType="pmc">PMC5390134</ArticleId><ArticleId IdType="pubmed">28366453</ArticleId></ArticleIdList></Reference><Reference><Citation>McLoon LK, Harandi VM, Br&#xe4;nnstr&#xf6;m T, Andersen PM, Liu JX. Wnt and extraocular muscle sparing in amyotrophic lateral sclerosis. Investig Ophthalmol Vis Sci. 2014;55(9):5482&#x2013;5496. doi: 10.1167/iovs.14-14886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.14-14886</ArticleId><ArticleId IdType="pmc">PMC4580151</ArticleId><ArticleId IdType="pubmed">25125606</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Guan Y, Chen Y, Li X, Zhang C, Yu L, et al. Role of Wnt1 and Fzd1 in the spinal cord pathogenesis of amyotrophic lateral sclerosis-transgenic mice. Biotechnol Lett. 2013;35(8):1199&#x2013;1207. doi: 10.1007/s10529-013-1199-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10529-013-1199-1</ArticleId><ArticleId IdType="pubmed">23553522</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Guan Y, Chen Y, Zhang C, Shi C, Zhou F, et al. Expression of Wnt5a and its receptor Fzd2 is changed in the spinal cord of adult amyotrophic lateral sclerosis transgenic mice. Int J Clin Exp Pathol. 2013;6(7):1245&#x2013;1260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3693190</ArticleId><ArticleId IdType="pubmed">23826406</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Guan Y, Zhang Z, Liu H, Wang S, Yu L, et al. Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice. Neurol Res. 2012;34(4):390&#x2013;399. doi: 10.1179/1743132812Y.0000000027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1743132812Y.0000000027</ArticleId><ArticleId IdType="pubmed">22643084</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Guan Y, Liu H, Wu X, Yu L, Wang S, et al. Activation of the Wnt/&#x3b2;-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice. Biochem Biophys Res Commun. 2012;420(2):397&#x2013;403. doi: 10.1016/j.bbrc.2012.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2012.03.006</ArticleId><ArticleId IdType="pubmed">22426476</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan T, Kazamel M, Thoenes K, Si Y, Jiang N, King PH. Wnt antagonist FRZB is a muscle biomarker of denervation atrophy in amyotrophic lateral sclerosis. Sci Rep. 2020;10(1):16679. doi: 10.1038/s41598-020-73845-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-73845-z</ArticleId><ArticleId IdType="pmc">PMC7541525</ArticleId><ArticleId IdType="pubmed">33028902</ArticleId></ArticleIdList></Reference><Reference><Citation>Halleskog C, Dijksterhuis JP, Kilander MBC, Becerril-Ortega J, Villaescusa JC, Lindgren E, et al. Heterotrimeric G protein-dependent WNT-5A signaling to ERK1/2 mediates distinct aspects of microglia proinflammatory transformation. J Neuroinflammation. 2012;9:111. doi: 10.1186/1742-2094-9-111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-111</ArticleId><ArticleId IdType="pmc">PMC3458933</ArticleId><ArticleId IdType="pubmed">22647544</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepore AC, Rauck B, Dejea C, Pardo AC, Rao MS, Rothstein JD, et al. Focal transplantation &#x2013; based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci. 2008;11(11):1294&#x2013;1301. doi: 10.1038/nn.2210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2210</ArticleId><ArticleId IdType="pmc">PMC2656686</ArticleId><ArticleId IdType="pubmed">18931666</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>